1 Min Read
Feb 14 (Reuters) - Mallinckrodt Plc:
* MALLINCKRODT ENROLLS FIRST PATIENT IN PHASE 1 STUDY OF EXPRESSGRAFT™C9T1 SKIN TISSUE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.